DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vibativ (Telavancin) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vibativ (Telavancin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (10)
Death (2)

Reports by Reaction Type

Chills (3)Blood Glucose Increased (3)Vomiting (3)Nausea (3)Tremor (3)Muscle Spasms (2)Extravasation (2)Electrocardiogram QT Prolonged (1)Disease Progression (1)Death (1)Hospitalisation (1)Thrombocytopenia (1)

Possible Vibativ side effects in female

Reported by a pharmacist from United States on 2012-02-21

Patient: female

Reactions: Death, Hospitalisation, Multiple-Drug Resistance, Disease Progression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vibativ



Possible Vibativ side effects in 78 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-30

Patient: 78 year old male, weighing 183.0 kg (402.6 pounds)

Reactions: Extravasation, Vomiting, Nausea, Chills, Blood Glucose Increased, Tremor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vibativ
    Dosage: 1800 mg, total dose
    Indication: Erysipelas
    Start date: 2011-11-21
    End date: 2011-11-21

Vibativ
    Dosage: 1000 mg, total dose
    Start date: 2011-11-22
    End date: 2011-11-22

Vibativ
    Dosage: 1800 mg, total dose
    Start date: 2011-11-23
    End date: 2011-11-23

Other drugs received by patient: Platelet Aggregation Inhibitors



Possible Vibativ side effects in 78 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-16

Patient: 78 year old male, weighing 182.3 kg (401.2 pounds)

Reactions: Vomiting, Nausea, Chills, Blood Glucose Increased, Tremor, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vibativ
    Dosage: telavancin 1800mg dly iv on 11/21/11
    Indication: Erysipeloid
    Start date: 2011-11-21
    End date: 2011-11-23

Vibativ
    Dosage: telavvancin 100mg



Possible Vibativ side effects in 78 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-07

Patient: 78 year old male, weighing 183.0 kg (402.6 pounds)

Reactions: Extravasation, Vomiting, Nausea, Chills, Blood Glucose Increased, Tremor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vibativ
    Dosage: 1800 mg, total dose
    Indication: Erysipelas
    Start date: 2011-11-21
    End date: 2011-11-21

Vibativ
    Dosage: 1000 mg, total dose
    Start date: 2011-11-22
    End date: 2011-11-22

Vibativ
    Dosage: 1800 mg, total dose
    Start date: 2011-11-23
    End date: 2011-11-23

Other drugs received by patient: Platelets



Possible Vibativ side effects in female

Reported by a physician from United States on 2011-11-28

Patient: female

Reactions: Renal Impairment, Thrombocytopenia

Drug(s) suspected as cause:
Vibativ



Possible Vibativ side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-21

Patient: 65 year old female

Reactions: Muscle Spasms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vibativ

Other drugs received by patient: Metoprolol Tartrate; Actos; Anastrozole; Antara (Micronized)



Possible Vibativ side effects in 38 year old female

Reported by a physician from United States on 2011-10-21

Patient: 38 year old female

Reactions: Muscle Spasms

Drug(s) suspected as cause:
Vibativ



Possible Vibativ side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-14

Patient: 60 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Electrocardiogram QT Prolonged

Drug(s) suspected as cause:
Lexapro
    Dosage: oral
    Administration route: Oral

Vibativ
    Dosage: 10 mg/kg total daily dose, intravenous (not otherwise specified)
    Indication: Cellulitis
    Start date: 2011-02-18
    End date: 2011-02-20

Trazodone HCL
    Dosage: oral
    Administration route: Oral

Other drugs received by patient: Metoprolol Tartrate; Fentanyl; Novolin R; Cilostazol; Lisinopril; Imdur; Vitamin D (Colecalciferol); Sitagliptin; Lasix; Hydromorphone HCL; Calcium Citrate; Omeprazole; Reglan; Zolpiderm; Lantus; Oxycodone HCL; Warfarin Sodium; Lipitor



Possible Vibativ side effects in male

Reported by a physician from United States on 2011-10-10

Patient: male

Reactions: Myocardial Infarction, Blood Creatinine Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Vibativ

Other drugs received by patient: Diuretic



Possible Vibativ side effects in 50 year old female

Reported by a physician from United States on 2011-10-04

Patient: 50 year old female

Reactions: Platelet Count Decreased

Drug(s) suspected as cause:
Invanz
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-29
    End date: 2011-08-17

Vibativ
    Dosage: unk
    Indication: Cellulitis
    Start date: 2011-07-29
    End date: 2011-08-17

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017